Identity
- Trade Name
- OBALON® Placebo Capsule FDA UDI
- Generic Name
- Appetite-suppression gastric balloon FDA UDI
- Device Name
- OBALON® Placebo Capsule - component for use with the OBALON® Balloon System FDA UDI
- Model / Reference
- 7150-0003 FDA UDI
- Description
- OBALON® Placebo Capsule - component for use with the OBALON® Balloon System FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00859810006005 FDA UDI
- PMA Number
- P160001 FDA UDI
- FDA Product Code
- LTI FDA UDI
- GMDN Term
- Appetite-suppression gastric balloon FDA UDI
Classification
- Device Class
- Class III FDA UDI
- Commercial Distribution
- Not in Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
Yes
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
OBALON® Placebo Capsule by ReShape Lifesciences Inc. — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class III | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- ReShape Lifesciences Inc.
Sources (1)
- FDA UDI 77aceefd-2ae6-46f6-97e4-85fc522dbf1d 37 fields · synced Jun 1, 2026